涅玛特里尔维尔/里托纳维尔:现实世界药物相互作用管理经验
Shahid Bukhari1, Stephen Hughes1, Nabeela Mughal1
1Chelsea and Westminster Hospital Foundation Trust, London, UK.
Expert review of anti-infective therapy
|August 7, 2024
概括
一项对伦敦COVID-19患者的研究发现了许多与nirmatrelvir/ritonavir的潜在药物相互作用. 经常需要管理,但没有一致的记录,强调需要临床药理学专业知识.
科学领域:
- 临床药理学 临床药理学
- 传染性疾病 传染性疾病
- 医疗保健服务研究 医疗服务研究
背景情况:
- 英国的COVID-19药物交付区域系统集中了专业知识.
- 这个系统有助于患者风险分层和药物相互作用 (DDI) 的管理.
研究的目的:
- 分析成年患者接受涅马特里尔维尔/里托纳维尔的现实药物相互作用.
- 评估伦敦医疗保健系统中这些相互作用的管理和记录.
主要方法:
- 对被转诊接受尼马特里尔维尔/里托纳维尔治疗的成年患者的回顾性分析.
- 评估已识别的潜在药物相互作用 (DDI) 及其管理.
主要成果:
- 在接受尼马特里尔维尔/里托纳维尔的208名患者中,发现了184名潜在的DDI.
- 8%的潜在DDI阻止了治疗,53%需要管理,56%缺乏记录的治疗建议.
结论:
- 现实世界的数据显示,与涅马特里尔维尔/里托纳维尔治疗相关的显著DDI.
- 维持和发展临床药理学途径对于有效的COVID-19管理至关重要.
相关概念视频
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Retrovirus Life Cycles
45.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.8K
Drug-Receptor Interactions
5.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.1K
Pharmacovigilance
801
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
801
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Combined Effects of Drugs: Antagonism
8.4K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.4K


